Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes:an individual patient data meta-analysis

Autor: Emmanuel Tsochatzis, Olivier Chazouillères, Jeremy F. L. Cobbold, Stephan Baumeler, Sylvie Naveau, Thomas Karlas, Maja Thiele, Vincent Wai-Sun Wong, David Semela, Gabriel Perlemuter, Harshit Garg, Cristiane A. Villela-Nogueira, Magali Sasso, Marie Irles-Depe, Monica Lupsor-Platon, Peter J Eddowes, David Sheridan, Cosmin Sebastian Voican, Aleksander Krag, Johannes Wiegand, Shalimar, Sebastian Mueller, Philip N. Newsome, Victor de Ledinghen, Michael Allison, Sandeep Aggarwal, Quentin M. Anstee, Wah-Kheong Chan, David Petroff, A.C. Cardoso, Valentin Blank, Grace Lai-Hung Wong

Publikováno v: Petroff, D, Blank, V, Newsome, P N, Shalimar, Voican, C S, Thiele, M, de Lédinghen, V, Baumeler, S, Chan, W K, Perlemuter, G, Cardoso, A-C, Aggarwal, S, Sasso, M, Eddowes, P J, Allison, M, Tsochatzis, E, Anstee, Q M, Sheridan, D, Cobbold, J F, Naveau, S, Lupsor-Platon, M, Mueller, S, Krag, A, Irles-Depe, M, Semela, D, Wong, G L-H, Wong, V W-S, Villela-Nogueira, C A, Garg, H, Chazouillères, O, Wiegand, J & Karlas, T 2021, ' Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes : an individual patient data meta-analysis ', The Lancet Gastroenterology & Hepatology, vol. 6, no. 3, pp. 185-198 . https://doi.org/10.1016/S2468-1253(20)30357-5

BACKGROUND: Diagnostic tools for liver disease can now include estimation of the grade of hepatic steatosis (S0 to S3). Controlled attenuation parameter (CAP) is a non-invasive method for assessing hepatic steatosis that has become available for pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc8a57f77278c1c2dc69e657e3b3a3b
https://findresearcher.sdu.dk:8443/ws/files/200070621/C614C342_3A7D_464D_90A1_15FEB6513143.pdf

Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP)

Autor: A.C. Cardoso, N Carvalho Leite, Cristiane A. Villela-Nogueira, Renata M. Perez, C de Figueiredo-Mendes, Henrique S. Moraes-Coelho

Publikováno v: Journal of Viral Hepatitis. 25:1244-1250

A novel controlled attenuation parameter (CAP) using FibroScan® has been developed for assessment of liver steatosis. The aim was to evaluate the frequency and associated factors for moderate/severe steatosis evaluated by CAP in CHC patients submitt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::384d0c7be642d24e374d72d97f1265f7
https://doi.org/10.1111/jvh.12930